|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0013216,
umls-concept:C0018943,
umls-concept:C0023981,
umls-concept:C0034656,
umls-concept:C0086409,
umls-concept:C0184511,
umls-concept:C0200627,
umls-concept:C0205087,
umls-concept:C0751606,
umls-concept:C1274040
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1998-6-10
|
|
pubmed:abstractText |
Intensive induction and post-remission therapies have improved the prognosis in adult acute lymphoblastic leukemia (ALL). However, different from children, the impact of late intensification therapy in the overall results of treatment has not been consistently evaluated. The objective of this study was to analyze the results of a multicenter prospective protocol, PETHEMA ALL-89, in which, after intensive induction and consolidation therapy, randomization to receive delayed intensification treatment was performed.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
pubmed-author:BesalduchJJ,
pubmed-author:BrunetSS,
pubmed-author:Domingo-AlbósAA,
pubmed-author:FeliuEE,
pubmed-author:FontanillasMM,
pubmed-author:García-CondeJJ,
pubmed-author:GardellaSS,
pubmed-author:Hernández-RivasJ MJM,
pubmed-author:LeónPP,
pubmed-author:MaciàJJ,
pubmed-author:MaldonadoJJ,
pubmed-author:OriolAA,
pubmed-author:OrtegaJ JJJ,
pubmed-author:RiberaJ MJM,
pubmed-author:San MiguelJ FJF,
pubmed-author:ZuazuJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
83
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
222-30
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9573676-Adolescent,
pubmed-meshheading:9573676-Adult,
pubmed-meshheading:9573676-Age Factors,
pubmed-meshheading:9573676-Aged,
pubmed-meshheading:9573676-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9573676-Drug Administration Schedule,
pubmed-meshheading:9573676-Female,
pubmed-meshheading:9573676-Humans,
pubmed-meshheading:9573676-Male,
pubmed-meshheading:9573676-Middle Aged,
pubmed-meshheading:9573676-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:9573676-Prognosis,
pubmed-meshheading:9573676-Prospective Studies,
pubmed-meshheading:9573676-Remission Induction,
pubmed-meshheading:9573676-Spain,
pubmed-meshheading:9573676-Survival Rate,
pubmed-meshheading:9573676-Time Factors,
pubmed-meshheading:9573676-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
|
|
pubmed:affiliation |
Hematology Department, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain. jmribera@as.hugtip.scs.es
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
